Skip to main content
Funded Studies

Tanya Simuni, MD, FAAN

Division Head at Northwestern University

Location: Chicago, IL United States

Dr. Tanya Simuni joined the faculty of the Northwestern University Feinberg School of Medicine in 2000 to build a multidisciplinary movement disorders center that is recognized by the Parkinson’s Foundation, Huntington Disease Society of America and Wilson’s Foundation as a Center of Excellence and serves as a training model in the region. She is the lead investigator for a number of clinical trials on experimental pharmacology, non-motor manifestations and pharmacological management of Parkinson’s disease (PD). She serves on a number of committees for PD national clinical trials, the Parkinson Study Group (PSG) and the Parkinson’s Foundation. She is the site PI for the largest PD biomarker initiative (PPMI study) and for the Network for Excellence in Neuroscience Clinical Trials (NEXT). Dr. Simuni is an active member of the American Academy of Neurology, American Neurological Association, the Movement Disorders Society as well as the PSG.


Associated Grants

  • Objectively Measuring the Severity of Vocal and Speech-related Symptoms Associated with Parkinson’s Disease

    2022


  • Phase IIa Safety and Tolerability Trial of Nilotinib in People with Parkinson's Disease

    2017


  • Planning Phase for a Phase IIa Study of Nilotinib in People with Parkinson's Disease

    2016


  • High resolution diffusion tensor MRI imaging as a biomarker of Parkinson Disease diagnosis and disease progression

    2009


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.